BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24470281)

  • 1. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Cockbain AJ; Volpato M; Race AD; Munarini A; Fazio C; Belluzzi A; Loadman PM; Toogood GJ; Hull MA
    Gut; 2014 Nov; 63(11):1760-8. PubMed ID: 24470281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
    Hull MA; Ow PL; Ruddock S; Brend T; Smith AF; Marshall H; Song M; Chan AT; Garrett WS; Yilmaz O; Drew DA; Collinson F; Cockbain AJ; Jones R; Loadman PM; Hall PS; Moriarty C; Cairns DA; Toogood GJ
    BMJ Open; 2023 Nov; 13(11):e077427. PubMed ID: 38030258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
    Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA
    Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis.
    West NJ; Clark SK; Phillips RK; Hutchinson JM; Leicester RJ; Belluzzi A; Hull MA
    Gut; 2010 Jul; 59(7):918-25. PubMed ID: 20348368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
    Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
    Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
    Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
    Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial.
    Higurashi T; Hosono K; Endo H; Takahashi H; Iida H; Uchiyama T; Ezuka A; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Maeda S; Morita S; Natsumeda Y; Nagase H; Nakajima A
    BMC Cancer; 2012 Sep; 12():413. PubMed ID: 22992267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.
    Watson H; Cockbain AJ; Spencer J; Race A; Volpato M; Loadman PM; Toogood GJ; Hull MA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():60-66. PubMed ID: 27914515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.
    Fini L; Piazzi G; Ceccarelli C; Daoud Y; Belluzzi A; Munarini A; Graziani G; Fogliano V; Selgrad M; Garcia M; Gasbarrini A; Genta RM; Boland CR; Ricciardiello L
    Clin Cancer Res; 2010 Dec; 16(23):5703-11. PubMed ID: 21030497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
    Piazzi G; D'Argenio G; Prossomariti A; Lembo V; Mazzone G; Candela M; Biagi E; Brigidi P; Vitaglione P; Fogliano V; D'Angelo L; Fazio C; Munarini A; Belluzzi A; Ceccarelli C; Chieco P; Balbi T; Loadman PM; Hull MA; Romano M; Bazzoli F; Ricciardiello L
    Int J Cancer; 2014 Nov; 135(9):2004-13. PubMed ID: 24676631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid incorporation of ω-3 fatty acids into colonic tissue after oral supplementation in patients with colorectal cancer: a randomized, placebo-controlled intervention trial.
    Sorensen LS; Rasmussen HH; Aardestrup IV; Thorlacius-Ussing O; Lindorff-Larsen K; Schmidt EB; Calder PC
    JPEN J Parenter Enteral Nutr; 2014 Jul; 38(5):617-24. PubMed ID: 23788002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.
    Hawcroft G; Loadman PM; Belluzzi A; Hull MA
    Neoplasia; 2010 Aug; 12(8):618-27. PubMed ID: 20689756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis.
    Scaioli E; Sartini A; Bellanova M; Campieri M; Festi D; Bazzoli F; Belluzzi A
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1268-1275.e2. PubMed ID: 29391271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases.
    Al-Taan O; Stephenson JA; Spencer L; Pollard C; West AL; Calder PC; Metcalfe M; Dennison AR
    Lipids Health Dis; 2013 May; 12():64. PubMed ID: 23648075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krill oil extract suppresses cell growth and induces apoptosis of human colorectal cancer cells.
    Jayathilake AG; Senior PV; Su XQ
    BMC Complement Altern Med; 2016 Aug; 16(1):328. PubMed ID: 27576529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart.
    Murphy MG; Wright V; Ackman RG; Horackova M
    Mol Cell Biochem; 1997 Dec; 177(1-2):257-69. PubMed ID: 9450671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind randomized controlled trial of the effects of eicosapentaenoic acid supplementation on muscle inflammation and physical function in patients undergoing colorectal cancer resection.
    Hossain T; Phillips BE; Doleman B; Lund JN; Williams JP
    Clin Nutr; 2020 Jul; 39(7):2055-2061. PubMed ID: 31648815
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.